ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,858Medicare Part D Prescriptions Filled, Including Refills

Rank: 125 out of 1454

$801K Total Retail Price of All Prescriptions

Rank: 173 out of 1454

479 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 479 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 479 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 11,832 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
OMEPRAZOLE 707 523 1 3
HYDROCODONE-ACETAMINOPHEN 538 360 S3 2 7
LEVOTHYROXINE SODIUM 496 382 3 5
SIMVASTATIN 496 403 3 1
GABAPENTIN 414 321 5 16
METFORMIN HCL 376 279 6 8
AMLODIPINE BESYLATE 369 321 7 2
FUROSEMIDE 341 281 8 6
WARFARIN SODIUM 297 227 9 17
LOVASTATIN 276 236 10 39
METOPROLOL TARTRATE 271 241 11 10
METOPROLOL SUCCINATE 257 202 12 13
CITALOPRAM HBR 236 172 13 21
LISINOPRIL 214 163 14 4
ATENOLOL 209 184 15 18
ZOLPIDEM TARTRATE 207 162 16 19
MELOXICAM 176 118 17 37
ALLOPURINOL 163 127 18 28
NAMENDA 157 157 19 48
MIRTAZAPINE 155 129 20 53
NEXIUM 149 88 21 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 144 120 22 27
ATORVASTATIN CALCIUM 141 83 23 11
POTASSIUM CHLORIDE 140 114 24 15
SINGULAIR 139 98 25 83
RANITIDINE HCL 137 132 26 43
PRAVASTATIN SODIUM 135 118 27 12
SERTRALINE HCL 135 118 27 26
BENAZEPRIL HCL 134 121 29 57
GLIPIZIDE XL 131 103 30 85
CARVEDILOL 125 110 31 24
TRAMADOL HCL 124 108 32 20
PANTOPRAZOLE SODIUM 123 103 33 31
HYDROCHLOROTHIAZIDE 122 115 34 9
DONEPEZIL HCL 121 120 35 29
ADVAIR DISKUS 120 72 36 47
AMITRIPTYLINE HCL 118 64 R 37 71
ISOSORBIDE MONONITRATE ER 115 106 38 46
GLIPIZIDE ER 108 69 39 92
PREDNISONE 108 63 39 36
CLOPIDOGREL 105 82 41 32
OXYCODONE HCL 105 46 S2 41 80
DIGOXIN 102 102 43 70
DIOVAN 102 102 43 40
ALENDRONATE SODIUM 100 89 45 35
TRAZODONE HCL 99 54 46 50
ESCITALOPRAM OXALATE 98 60 47 78
PROAIR HFA 97 64 48 56
GLIPIZIDE 97 79 48 62
LOSARTAN POTASSIUM 94 55 50 14
CYCLOBENZAPRINE HCL 90 38 R 51 59
MONTELUKAST SODIUM 89 63 52 144
FLUTICASONE PROPIONATE 86 63 53 30
BUMETANIDE 82 63 54 149
ENALAPRIL MALEATE 80 66 55 58
TAMSULOSIN HCL 79 64 56 34
GEMFIBROZIL 79 68 56 128
TRIAMTERENE-HCTZ 78 78 58 44
METOCLOPRAMIDE HCL 77 43 59 121
DOXAZOSIN MESYLATE 71 71 60 87
SYNTHROID 69 51 61 25
COMBIVENT 65 34 62 115
DILTIAZEM 24HR CD 63 51 63 76
AMOX TR-POTASSIUM CLAVULANATE 62 46 64 148
PLAVIX 60 50 65 45
CRESTOR 60 44 65 22
RAMIPRIL 59 47 67 66
JANUVIA 58 29 68 77
CIPROFLOXACIN HCL 57 48 69 64
VENLAFAXINE HCL ER 56 35 70 105
DIOVAN HCT 56 48 70 75
AMLODIPINE BESYLATE-BENAZEPRIL 55 50 72 65
NITROSTAT 54 51 73 208
OXYCODONE-ACETAMINOPHEN 53 19 S2 74 60
DILTIAZEM ER 53 51 74 126
MECLIZINE HCL 52 51 76 132
FENTANYL 52 0 S2 76 104
PROMETHAZINE HCL 52 34 R 76 82
KLOR-CON M20 52 40 76 54
KLOR-CON 10 52 29 76 141
CLONIDINE HCL 51 23 81 49
OXYCODONE HCL-ACETAMINOPHEN 50 12 S2 82 93
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 29, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.